Hamden, CTNCT07499232Now EnrollingIRB Ready

Crohn Disease Clinical Trial in Hamden, CT

Access cutting-edge crohn disease treatment through this clinical trial at a research site in Hamden. Study-provided care at no cost to qualified participants.

Sponsored by Janssen Research & Development, LLC

Quick Self-Assessment

See if you qualify for this Hamden location

Preparing your pre-screening questions…

Expert Care in Hamden

Access crohn disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related crohn disease treatment provided free

Apply for This Hamden Location

Check if you qualify for this crohn disease clinical trial in Hamden, CT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Hamden

    Convenient for CT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Hamden site if eligible
  4. 4Begin participation

About This Crohn Disease Study in Hamden

The purpose of this study is to assess how well guselkumab works when compared to risankizumab in participants with moderately to severely active Crohn's Disease (CD; a long-term condition causing severe inflammation of the intestinal tract).

Sponsor: Janssen Research & Development, LLC

Who Can Participate

Inclusion Criteria

Has CD or fistulizing Crohn's Disease (CD) of at least 12 weeks' duration, with colitis, ileitis, or ileocolitis, confirmed at some time in the past by radiography, histology, and/or endoscopy
Have moderately to severely active CD, defined as baseline Crohn's Disease Activity Index (CDAI) score greater than or equal to (\>=) 220 but less than or equal to (\<=) 450
Baseline endoscopic evidence of active ileal and/or colonic CD as assessed by central endoscopy reading at the screening endoscopy defined as a screening Simple Endoscopic Score for Crohn's Disease (SES CD) \>= 4 (for participants with isolated ileal disease) or \>= 6 (for participants with colonic or ileocolonic disease), based on the presence of ulceration in any 1 of the 5 ileocolonic segments, resulting in the following specified ulceration component scores:
a minimum score of 1 for the component of "size of ulcers" AND
a minimum score of 1 for the component of "ulcerated surface"
In the opinion of the investigator, participant's disease is appropriate to treat with the maintenance dosing regimens utilized in the study
Adhere to the requirements for concomitant medications for the treatment of CD as mentioned in the protocol

Exclusion Criteria

Has complications of CD such as symptomatic strictures or stenoses, short gut syndrome, active draining stoma or significant fistulizing disease or any other manifestation anticipated to require surgery within the next year, could preclude the use of the CDAI to assess response to therapy, or would possibly confound the ability to assess the effect of treatment with guselkumab or risankizumab
Currently has or is suspected to have an abscess
Has an active fistula during screening or at Week 0 with an anticipated need for surgery
Has had any kind of bowel resection within 24 weeks, or any other intra-abdominal or other major surgery within 12 weeks, before first dose of study intervention
Currently has a malignancy or has a history of malignancy within 5 years before screening

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Hamden?

Yes, this clinical trial (NCT07499232) has an active research site in Hamden, CT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Crohn Disease Treatment Options in Hamden, CT

If you're searching for crohn disease treatment options in Hamden, CT, this clinical trial (NCT07499232) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Hamden research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all crohn disease clinical trials near you to find additional studies recruiting in your area.

More Crohns Disease Trials in Hamden, CT

See all crohns disease clinical trials recruiting in Hamden — not just this study.

Browse Crohns Disease Trials in Hamden →

Browse More Trials by Condition

Crohns Disease TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Hamden?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Hamden, CT